Quotient
QTNT
$0.38
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Operating Margin for Quotient (QTNT)
Operating Margin as of April 2024 (TTM): -237.32%
According to Quotient's latest financial reports and stock price the company's current Operating Margin is -237.32%. At the end of 2022 the company had an Operating Margin of -322.40%.
Operating Margin history for Quotient from 2013 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -322.40% | 31.26% |
| 2021 | -245.61% | -21.45% |
| 2020 | -312.69% | -13.52% |
| 2019 | -361.58% | 7.76% |
| 2018 | -335.55% | -12.33% |
| 2017 | -382.73% | 109.25% |
| 2016 | -182.91% | -42.99% |
| 2015 | -320.83% | 523.52% |
| 2014 | -51.46% | 56.87% |
| 2013 | -32.80% | -10.39% |
| 2012 | -36.61% | -20.51% |
| 2011 | -46.05% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Atossa Therapeutics ATOS | -725,722.00% | 305,698.92% | 🇺🇸 USA |
 Chembio Diagnostics CEMI | -91.98% | -61.24% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.